India waives off clinical trials for 5 drugs approved in US, UK, EU, Japan, Australia, Canada
DCGI lists categories of drugs eligible for this concession, including orphan drugs for rare diseases and new drugs used in pandemic situations
clinical trials
August 2024
February 2022
India now prime destination for big pharma's global clinical trials
India's clinical trials market is expected to reach $3.15 billion by 2025 with a compounded annual growth rate of 8.7%.
